Pub. Date : 2021 Apr
PMID : 33617901
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The FDA and EMA has recently approved olaparib, a Poly (ADP-ribose) polymerase (PARP) inhibitor, as a maintenance strategy for platinum-sensitive advanced PDAC patients with BRCA mutations. | Platinum | poly(ADP-ribose) polymerase 1 | Homo sapiens |